Molecular Grafting Unit
On the 23rd November the permanent commission of the Région Nouvelle-Aquitaine approved the award of an innovation subsidy to AVE for investment in a commercial-scale molecular grafting unit.
AVE <> Airbus BizLab
AVE has been selected by Airbus to join the 4th season of the Airbus acceleration programme BizLab Toulouse. More information is available on the AVE website:
Quantum Simulation Team
AVE is raising capital to develop a quantum molecular simulation team to accelerate our existing mathematical based approach to molecular grafting.
Quantum simulation will allow us to shorten the development time of new chimera polymers with wide ranging applications from production of ultra-high performance products through to encryption and biosynthetic pharmaceuticals.
AVE's firs chimera polymer, Xylium, is available for commercialisation.
XYLIUM is the first in AVE's series of chimera polymers. Helium filled micro-capsules have been molecularly grafted to epoxy in order to produce an ultra lightweight composite. XYLIUM has applications in which ultra light composites are required that do not compromise on mechanical properties: marine / yachting industry, auto-sports and mainstream car products, aviation, sports equipment etc.
Participate in AVE's future - register your interest here:
AVE's molecular grafting technology plateform will form the basis of a new generation of smart nano materials. AVE is looking to develop its network of customers, partners, and investors to participate in its future. Register your interest by following the link below: